These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36613623)

  • 21. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 23. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models.
    Chai AB; Hartz AMS; Gao X; Yang A; Callaghan R; Gelissen IC
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
    Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
    J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ.
    Miners JS; Clarke P; Love S
    Brain Pathol; 2017 May; 27(3):305-313. PubMed ID: 27248362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.
    Zandl-Lang M; Fanaee-Danesh E; Sun Y; Albrecher NM; Gali CC; Čančar I; Kober A; Tam-Amersdorfer C; Stracke A; Storck SM; Saeed A; Stefulj J; Pietrzik CU; Wilson MR; Björkhem I; Panzenboeck U
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):40-60. PubMed ID: 28941799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain.
    Swaminathan SK; Ahlschwede KM; Sarma V; Curran GL; Omtri RS; Decklever T; Lowe VJ; Poduslo JF; Kandimalla KK
    J Cereb Blood Flow Metab; 2018 May; 38(5):904-918. PubMed ID: 28569090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
    Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis.
    Goldwaser EL; Acharya NK; Wu H; Godsey GA; Sarkar A; DeMarshall CA; Kosciuk MC; Nagele RG
    J Alzheimers Dis; 2020; 74(1):345-361. PubMed ID: 32039847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
    Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
    Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    Parodi-Rullán R; Sone JY; Fossati S
    J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling.
    Park R; Kook SY; Park JC; Mook-Jung I
    Cell Death Dis; 2014 Jun; 5(6):e1299. PubMed ID: 24967961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.
    Deane R; Sagare A; Hamm K; Parisi M; LaRue B; Guo H; Wu Z; Holtzman DM; Zlokovic BV
    J Neurosci; 2005 Dec; 25(50):11495-503. PubMed ID: 16354907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease.
    Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Sarkar S
    Neuroscience; 2020 Aug; 440():48-55. PubMed ID: 32450297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.